Publication
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma
Evaluation of soluble MAdCAM-1 as a prognostic biomarker in metastatic renal cell carcinoma, linking clinical outcomes to gut microbiota composition and immune regulation across three independent clinical trials.
Citation
Alves Costa Silva C†, Machaalani M†, Saliby RM†, Zhong C, Xie W, Pasolli E, Piccinno G, Dalban C, Fidelle M, Meurisse A, Vernerey D, Lee GS, Birebent R, Saad E, Steiner C, Flippot R, Barros-Monteiro J, Segata N, Thiery-Vuillemin A, Formenti S, Kuznetsova T, Escudier B, Derosa L, Zitvogel L, Albiges L. Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma. Nature Medicine. 2026. doi:10.1038/s41591-025-04067-x. †Equal contribution.